spacer
home > pmps > summer 2002 > aluminium foil - a versatile tool for pharmaceutical packaging
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Aluminium Foil - A Versatile Tool for Pharmaceutical Packaging

Aluminium foil (alufoil) has been a primary material used in the protective packaging of pharmaceutical tablets since the introduction of the double-sided 'strip' pack in the 1950s. Since then, it has been an important means of protection and single unit presentation of compressed tablets and, more recently, of an enormous variety of new pharmaceutical products.

As medical and pharmaceutical science progresses, so must the packaging solutions essential to the task of delivering drugs to the point of use. A good example of this is the use of an alufoil laminated blister pack as a mould for forming tablets which are dosed into the foil tray in aqueous form and then freeze dried. Increasing demands for tamper evidence, anti-counterfeit measures and child-resistant access are all being successfully addressed by alufoil-based packaging.

There are several reasons why alufoil has gained such a strong position in the pharmaceutical packaging market, these include:


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Stefan Glimm, Secretary General of the European Aluminium Foil Association A Political Economist by discipline, Stefan Glimm has been Executive Director of the Gesamtverband der Aluminiumindustrie e.V. (GDA - the German Aluminium Industry Association) since 1992. He was appointed Secretary General of the European Aluminium Foil Association (EAFA) in 2000 having also worked with that association for several years.
He has previously been active in various capacities at the Wirtschaftvereinigung Metalle e.V. (WVM - the German Metals Federation), the European Aluminium Association (EAA) and the United Nations Environment Programme (UNEP).

spacer
Stefan Glimm
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers
 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement